SILVER DIGITAL INNOVATION PARTNER
Vetigenics creates novel immunotherapies to treat cancer and chronic disease in dogs without debilitating side effects. Our fully canine phage display libraries, enable rapid isolation of unique scFvs or CANIBODIES™ to any antigen based binding affinity, functionality and developability. CANIBODIES™ are entirely generated from naïve, canine immunoglobulin genes, requiring no caninization or affinity maturation, ready for formulating into mAbs, BiTEs, or CAR-T. CANIBODIES™ are designed for precision, efficacy and lack of immunogenicity, not possible with any other discovery approaches.
MEET OUR TEAM